COLLEEN BROWN: Open Payments
NPI 1154656890 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 9 companies in 2025. Trend: 2023 $732 · 2024 $782 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Astellas Pharma US Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Veozah, AIRSUPRA, Cologuard Collection Kit, VRAYLAR, QULIPTA, SHINGRIX, NURTEC ODT, BREZTRI.
Industry payments across OH — which companies pay providers there.
